Portfolio Update

Finsbury Worldwide Pharm Tst PLC 02 April 2004 2 April 2004 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC (the 'Company') QUARTERLY STATEMENT OF INVESTMENTS In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii), the Company discloses the following: • Investments valuing greater than 5% of the Company's gross assets comprise the following: Company Name Value of Investment at % of Total Portfolio Assets 31March 2004 Genentech Inc 15,140,191 6.71 Pfizer 12,396,278 5.49 • The ten largest investments held by the Company comprise the following: Company Name Value of Investment at % of Total 31 March 2004 Portfolio Assets Genentech Inc 15,140,191 6.71 Pfizer 12,396,278 5.49 Altana AG 10,872,923 4.82 Novartis 10,670,697 4.73 Amgen 10,579,584 4.69 Genzyme Corp General Division 10,245,667 4.54 Lilly (Eli) & Company 10,192,344 4.52 Given Imaging 9,055,568 4.01 Schering-Plough Corporation 8,820,089 3.91 Serona SA 'B' 8,727,156 3.87 - ENDS - For further information please contact: Tracey Gower, Company Secretary Close Finsbury Asset Management Limited Telephone: 020 7426 6219 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings